1-2 of 2
Bo Yang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SARS-CoV-2 ORF10 impairs cilia by enhancing CUL2ZYG11B activity

In Special Collection:
The Year in Cell Biology: 2022
Liying Wang, Chao Liu, Bo Yang, Haotian Zhang, Jian Jiao, Ruidan Zhang, Shujun Liu, Sai Xiao, Yinghong Chen, Bo Liu, Yanjie Ma, Xuefeng Duan, Yueshuai Guo, Mengmeng Guo, Bingbing Wu, Xiangdong Wang, Xingxu Huang, Haitao Yang, Yaoting Gui, Min Fang, Luo Zhang, Shuguang Duo, Xuejiang Guo, Wei Li
Journal: Journal of Cell Biology
J Cell Biol (2022) 221 (7): e202108015.
https://doi.org/10.1083/jcb.202108015
Published: 08 June 2022
View article titled, SARS-CoV-2 ORF10 impairs cilia by enhancing CUL2ZYG11B activity
Open the PDF for SARS-CoV-2 ORF10 impairs cilia by enhancing CUL2ZYG11B activity in another window
Includes: Supplementary data
Journal Articles

Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma

In Special Collection:
Scientific and Technical Advances in Cancer Immunology 2019
Jing Liu, Wenna Jiang, Kaili Zhao, Hongwei Wang, Tianxing Zhou, Weiwei Bai, Xiuchao Wang, Tiansuo Zhao, Chongbiao Huang, Song Gao, Tai Qin, Wenwen Yu, Bo Yang, Xin Li, Danqi Fu, Wei Tan, Shengyu Yang, He Ren, Jihui Hao
Journal: Journal of Experimental Medicine
J Exp Med (2019) 216 (3): 656–673.
https://doi.org/10.1084/jem.20180749
Published: 07 February 2019
View article titled, Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma
Open the PDF for Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma in another window
Includes: Supplementary data